Rare
lephants
Screener
Toggle theme
Ensysce Biosciences, Inc.
ENSC
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
-215.4%
-215.4%
-142.7%
FY2025
-316.6%
-316.6%
-136.5%
Download CSV
